Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeon, Min-Tae | - |
dc.contributor.author | Kim, Kyu-Sung | - |
dc.contributor.author | Kim, Eun Seon | - |
dc.contributor.author | Lee, Suji | - |
dc.contributor.author | Kim, Jieun | - |
dc.contributor.author | Hoe, Hyang-Sook | - |
dc.contributor.author | Kim, Do-Geun | - |
dc.date.accessioned | 2021-10-08T02:30:04Z | - |
dc.date.available | 2021-10-08T02:30:04Z | - |
dc.date.created | 2021-04-15 | - |
dc.date.issued | 2021-07 | - |
dc.identifier.issn | 1568-1637 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.11750/15444 | - |
dc.description.abstract | The responses of central nervous system (CNS) cells such as neurons and glia in neurodegenerative diseases (NDs) suggest that regulation of neuronal and glial functions could be a strategy for ND prevention and/or treatment. However, attempts to develop such therapeutics for NDs have been hindered by the challenge of blood-brain barrier (BBB) permeability and continued constitutive neuronal loss. These limitations indicate the need for additional perspectives for the prevention/treatment of NDs. In particular, the disruption of the blood-brain barrier (BBB) that accompanies NDs allows brain infiltration by peripheral factors, which may stimulate innate immune responses involved in the progression of neurodegeneration. The accumulation of blood factors like thrombin, fibrinogen, c-reactive protein (CRP) and complement components in the brain has been observed in NDs and may activate the innate immune system in the CNS. Thus, strengthening the integrity of the BBB may enhance its protective role to attenuate ND progression and functional loss. In this review, we describe the innate immune system in the CNS and the contribution of blood factors to the role of the CNS immune system in neurodegeneration and neuroprotection. © 2021 The Authors | - |
dc.language | English | - |
dc.publisher | Elsevier BV | - |
dc.title | Emerging pathogenic role of peripheral blood factors following BBB disruption in neurodegenerative disease | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.arr.2021.101333 | - |
dc.identifier.wosid | 000663077400004 | - |
dc.identifier.scopusid | 2-s2.0-85103708242 | - |
dc.identifier.bibliographicCitation | Ageing Research Reviews, v.68, pp.101333 | - |
dc.description.isOpenAccess | TRUE | - |
dc.subject.keywordAuthor | Blood factors | - |
dc.subject.keywordAuthor | Blood-brain barrier | - |
dc.subject.keywordAuthor | Immune system | - |
dc.subject.keywordAuthor | Neurodegenerative diseases | - |
dc.subject.keywordAuthor | Neuroinflammation | - |
dc.subject.keywordPlus | TOLL-LIKE RECEPTOR | - |
dc.subject.keywordPlus | ALZHEIMERS-DISEASE | - |
dc.subject.keywordPlus | AMYLOID-BETA | - |
dc.subject.keywordPlus | PROTHROMBIN KRINGLE-2 | - |
dc.subject.keywordPlus | MICROGLIAL ACTIVATION | - |
dc.subject.keywordPlus | DOPAMINERGIC-NEURONS | - |
dc.subject.keywordPlus | MOUSE MODEL | - |
dc.subject.keywordPlus | C-REACTIVE PROTEIN | - |
dc.subject.keywordPlus | BRAIN-BARRIER PERMEABILITY | - |
dc.subject.keywordPlus | CENTRAL-NERVOUS-SYSTEM | - |
dc.citation.startPage | 101333 | - |
dc.citation.title | Ageing Research Reviews | - |
dc.citation.volume | 68 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology; Geriatrics & Gerontology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology; Geriatrics & Gerontology | - |
dc.type.docType | Review | - |
There are no files associated with this item.